Pairing sky-mapping algorithms with advanced immunofluorescence imaging of cancer biopsies, researchers developed a robust platform to guide immunotherapy by predicting which cancers will respond to specific therapies targeting the immune system.
Pairing sky-mapping algorithms with advanced immunofluorescence imaging of cancer biopsies, researchers developed a robust platform to guide immunotherapy by predicting which cancers will respond to specific therapies targeting the immune system.